Abstract:Alteration of the lung microbiome has been observed in several respiratory tract diseases. However, most previous studies were based on 16S ribosomal RNA and shotgun metagenome sequencing; the viability and functional activity of the microbiome, as well as its interaction with host immune systems, have not been well studied. To characterize the active lung microbiome and its associations with host immune response and clinical features, we applied metatranscriptome sequencing to bronchoalveolar lavage fluid (BALF) samples from 25 patients with chronic obstructive pulmonary disease (COPD) and from nine control cases without known pulmonary disease. Community structure analyses revealed three distinct microbial compositions, which were significantly correlated with bacterial biomass, human Th17 immune response, and COPD exacerbation frequency. Specifically, samples with transcriptionally active Streptococcus, Rothia, or Pseudomonas had bacterial loads 16 times higher than samples enriched for Escherichia and Ralstonia. These high-bacterial-load samples also tended to undergo a stronger Th17 immune response. Furthermore, an increased proportion of lymphocytes was found in samples with active Pseudomonas. In addition, COPD patients with active Streptococcus or Rothia infections tended to have lower rates of exacerbations than patients with active Pseudomonas and patients with lower bacterial biomass. Our results support the idea of a stratified structure of the active lung microbiome and a significant host-microbe interaction. We speculate that diverse lung microbiomes exist in the population and that their presence and activities could either influence or reflect different aspects of lung health.IMPORTANCE Recent studies of the microbiome proposed that resident microbes play a beneficial role in maintaining human health. Although lower respiratory tract disease is a leading cause of sickness and mortality, how the lung microbiome interacts with human health remains largely unknown. Here we assessed the association between the lung microbiome and host gene expression, cytokine concentration, and over 20 clinical features. Intriguingly, we found a stratified structure of the active lung microbiome which was significantly associated with bacterial biomass, lymphocyte proportion, human Th17 immune response, and COPD exacerbation frequency. These observations suggest that the microbiome plays a significant role in lung homeostasis. Not only microbial composition but also active functional elements and host immunity characteristics differed among different individuals. Such diversity may partially account for the variation in susceptibility to particular diseases.

The Lung Microbiome

Transcriptionally Active Lung Microbiome And Its Association With Bacterial Biomass And Host Inflammatory Status

The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease

The Lung Microbiome during Health and Disease

The dynamic lung microbiome in health and disease

Lung microbiome: new insights into the pathogenesis of respiratory diseases

The lung microbiome: clinical and therapeutic implications

The human lung microbiome—A hidden link between microbes and human health and diseases

Role of Lung Microbiome in Innate Immune Response Associated With Chronic Lung Diseases

Emerging Cellular and Molecular Interactions Between the Lung Microbiota and Lung Diseases

The lung, the niche, and the microbe: Exploring the lung microbiome in cancer and immunity

The Human Respiratory Microbiome: Current Understandings and Future Directions

Lung microbiota: implications and interactions in chronic pulmonary diseases

Lung Microbiota and Its Impact on the Mucosal Immune Phenotype

Exploring the lung microbiome's role in disease

The Lung Microbiome: A Central Mediator of Host Inflammation and Metabolism in Lung Cancer Patients?

Role of Microbiota on Lung Homeostasis and Diseases

Role of the Lung Microbiome in the Pathogenesis of Chronic Obstructive Pulmonary Disease

Role of the lung microbiome in the pathogenesis of chronic obstructive pulmonary disease.

Microbiome effects on immunity, health and disease in the lung